Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	1-phosphatidylinositol-5-phosphate 4-kinase activity	PIP4K2A PIP4K2B PIP4K2C	9.78e-08	3	93	3	GO:0016309
GeneOntologyMolecularFunction	1-phosphatidylinositol-4-phosphate 5-kinase activity	PIP4K2A PIP4K2B PIP4K2C	8.05e-06	9	93	3	GO:0016308
GeneOntologyMolecularFunction	neurotrophin receptor activity	NTRK2 NTRK3	2.13e-04	5	93	2	GO:0005030
GeneOntologyMolecularFunction	phosphatidylinositol kinase activity	PIP4K2A PIP4K2B PIP4K2C	2.35e-04	26	93	3	GO:0052742
GeneOntologyMolecularFunction	transferase activity, transferring phosphorus-containing groups	CDK20 NTRK2 NTRK3 PIP4K2A HTATIP2 DLG1 PIP4K2B TNKS PIP4K2C TNKS2 MAST2 STK31 EPHA3	3.97e-04	938	93	13	GO:0016772
GeneOntologyMolecularFunction	GPI-linked ephrin receptor activity	NTRK3 EPHA3	4.44e-04	7	93	2	GO:0005004
GeneOntologyMolecularFunction	kinase activity	CDK20 NTRK2 NTRK3 PIP4K2A HTATIP2 DLG1 PIP4K2B PIP4K2C MAST2 STK31 EPHA3	8.40e-04	764	93	11	GO:0016301
GeneOntologyMolecularFunction	lipid kinase activity	PIP4K2A PIP4K2B PIP4K2C	9.17e-04	41	93	3	GO:0001727
GeneOntologyBiologicalProcess	1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate biosynthetic process	PIP4K2A PIP4K2B PIP4K2C	9.47e-08	3	95	3	GO:1902635
GeneOntologyBiologicalProcess	1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate metabolic process	PIP4K2A PIP4K2B PIP4K2C	3.77e-07	4	95	3	GO:1902633
GeneOntologyCellularComponent	postsynaptic membrane	CACNA1E ANK2 PTPRF NTRK2 NTRK3 DDN DLG1 SLITRK3 VDAC1	9.52e-05	405	95	9	GO:0045211
Domain	PInositol-4-P-5-kinase	PIP4K2A PIP4K2B PIP4K2C	4.40e-06	7	95	3	IPR023610
Domain	PIPKc	PIP4K2A PIP4K2B PIP4K2C	7.01e-06	8	95	3	SM00330
Domain	-	PIP4K2A PIP4K2B PIP4K2C	7.01e-06	8	95	3	3.30.800.10
Domain	PIP5K	PIP4K2A PIP4K2B PIP4K2C	7.01e-06	8	95	3	PF01504
Domain	PIPK	PIP4K2A PIP4K2B PIP4K2C	7.01e-06	8	95	3	PS51455
Domain	PInositol-4-P-5-kinase_N	PIP4K2A PIP4K2B PIP4K2C	7.01e-06	8	95	3	IPR027484
Domain	PInositol-4-P-5-kinase_C	PIP4K2A PIP4K2B PIP4K2C	7.01e-06	8	95	3	IPR027483
Domain	-	PIP4K2A PIP4K2B PIP4K2C	7.01e-06	8	95	3	3.30.810.10
Domain	PInositol-4-P-5-kinase_core	PIP4K2A PIP4K2B PIP4K2C	7.01e-06	8	95	3	IPR002498
Domain	TPKR_C2	NTRK2 NTRK3	7.65e-05	3	95	2	PF16920
Domain	Tyr_kinase_NGF_rcpt	NTRK2 NTRK3	7.65e-05	3	95	2	IPR020777
Domain	NTRK_C2	NTRK2 NTRK3	7.65e-05	3	95	2	IPR031635
Domain	Lectin_leg	LMAN2L LMAN2	1.53e-04	4	95	2	IPR005052
Domain	MAP7_fam	MAP7D3 MAP7D2	1.53e-04	4	95	2	IPR008604
Domain	L_LECTIN_LIKE	LMAN2L LMAN2	1.53e-04	4	95	2	PS51328
Domain	Lectin_leg-like	LMAN2L LMAN2	1.53e-04	4	95	2	PF03388
Domain	MAP7	MAP7D3 MAP7D2	1.53e-04	4	95	2	PF05672
Domain	HELP	EML5 EML6	3.79e-04	6	95	2	PF03451
Domain	HELP	EML5 EML6	3.79e-04	6	95	2	IPR005108
Domain	Galactose-bd-like	GUSB LAMA1 PCSK7 EPHA3	1.35e-03	94	95	4	IPR008979
Domain	SAM_2	TNKS TNKS2 EPHA3	1.36e-03	43	95	3	PF07647
Domain	Tyr_kinase_rcpt_2_CS	NTRK2 NTRK3	1.37e-03	11	95	2	IPR002011
Domain	RECEPTOR_TYR_KIN_II	NTRK2 NTRK3	1.63e-03	12	95	2	PS00239
Domain	MORN	MORN1 ALS2CL	2.24e-03	14	95	2	SM00698
Domain	MORN	MORN1 ALS2CL	2.57e-03	15	95	2	IPR003409
Domain	MORN	MORN1 ALS2CL	2.57e-03	15	95	2	PF02493
Domain	Poly(ADP-ribose)pol_cat_dom	TNKS TNKS2	3.31e-03	17	95	2	IPR012317
Domain	PARP_CATALYTIC	TNKS TNKS2	3.31e-03	17	95	2	PS51059
Domain	PARP	TNKS TNKS2	3.31e-03	17	95	2	PF00644
Domain	-	TNKS TNKS2	3.31e-03	17	95	2	3.90.228.10
Domain	Apc4_WD40_dom	EML5 EML6	4.58e-03	20	95	2	IPR024977
Domain	ANAPC4_WD40	EML5 EML6	4.58e-03	20	95	2	PF12894
Domain	Ank_2	ANK2 BCORL1 ANKDD1B TNKS TNKS2	4.84e-03	215	95	5	PF12796
Domain	-	GUSB PCSK7 EPHA3	6.13e-03	73	95	3	2.60.120.260
Pathway	REACTOME_PI5P_REGULATES_TP53_ACETYLATION	PIP4K2A PIP4K2B PIP4K2C	1.01e-05	9	71	3	M27655
Pathway	REACTOME_PI5P_REGULATES_TP53_ACETYLATION	PIP4K2A PIP4K2B PIP4K2C	1.01e-05	9	71	3	MM15357
Pathway	REACTOME_RECEPTOR_TYPE_TYROSINE_PROTEIN_PHOSPHATASES	PTPRF NTRK3 SLITRK3	1.31e-04	20	71	3	M27290
Pathway	REACTOME_RECEPTOR_TYPE_TYROSINE_PROTEIN_PHOSPHATASES	PTPRF NTRK3 SLITRK3	1.31e-04	20	71	3	MM14991
Pathway	REACTOME_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK	NTRK2 NTRK3 PIP4K2A PIP4K2B PIP4K2C	2.59e-04	113	71	5	MM14783
Pathway	REACTOME_INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS	NTRK2 NTRK3 PIP4K2A PIP4K2B TNKS PIP4K2C TNKS2	2.69e-04	252	71	7	MM15585
Pathway	REACTOME_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK	NTRK2 NTRK3 PIP4K2A PIP4K2B PIP4K2C	3.16e-04	118	71	5	M713
Pathway	REACTOME_PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES	PTPRF NTRK3 DLG1 SLITRK3	3.56e-04	67	71	4	MM15327
Pathway	REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_ACETYLATION	PIP4K2A PIP4K2B PIP4K2C	4.07e-04	29	71	3	MM15340
Pathway	REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_ACETYLATION	PIP4K2A PIP4K2B PIP4K2C	4.51e-04	30	71	3	M27637
Pathway	REACTOME_CARGO_CONCENTRATION_IN_THE_ER	MIA3 LMAN2L LMAN2	5.99e-04	33	71	3	M27591
Pathway	REACTOME_CARGO_CONCENTRATION_IN_THE_ER	MIA3 LMAN2L LMAN2	7.76e-04	36	71	3	MM15300
Pathway	REACTOME_PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES	PTPRF NTRK3 DLG1 SLITRK3	9.60e-04	87	71	4	M27617
Pathway	REACTOME_INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS	NTRK2 NTRK3 PIP4K2A PIP4K2B TNKS PIP4K2C TNKS2	9.80e-04	313	71	7	M27867
Pathway	KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_VGCC_CA2_APOPTOTIC_PATHWAY_N01006	PPID VDAC1	1.10e-03	10	71	2	M47694
Pubmed	Functional analysis of the biochemical activity of mammalian phosphatidylinositol 5 phosphate 4-kinase enzymes.	PIP4K2A PIP4K2B PIP4K2C	2.04e-08	3	96	3	30718367
Pubmed	The function of phosphatidylinositol 5-phosphate 4-kinase γ (PI5P4Kγ) explored using a specific inhibitor that targets the PI5P-binding site.	PIP4K2A PIP4K2B PIP4K2C	2.04e-08	3	96	3	25495341
Pubmed	Evolutionarily conserved structural changes in phosphatidylinositol 5-phosphate 4-kinase (PI5P4K) isoforms are responsible for differences in enzyme activity and localization.	PIP4K2A PIP4K2B PIP4K2C	2.04e-08	3	96	3	23758345
Pubmed	The Lipid Kinase PI5P4Kβ Is an Intracellular GTP Sensor for Metabolism and Tumorigenesis.	PIP4K2A PIP4K2B PIP4K2C	2.04e-08	3	96	3	26774281
Pubmed	A new pathway for synthesis of phosphatidylinositol-4,5-bisphosphate.	PIP4K2A PIP4K2B PIP4K2C	8.14e-08	4	96	3	9367159
Pubmed	PIP4Ks Suppress Insulin Signaling through a Catalytic-Independent Mechanism.	PIP4K2A PIP4K2B PIP4K2C	8.14e-08	4	96	3	31091439
Pubmed	Localization of mRNAs for phosphatidylinositol phosphate kinases in the mouse brain during development.	PIP4K2A PIP4K2B PIP4K2C	7.08e-07	7	96	3	15018809
Pubmed	Btk-dependent regulation of phosphoinositide synthesis.	PIP4K2A PIP4K2B PIP4K2C	1.13e-06	8	96	3	15046600
Pubmed	PI(5)P regulates autophagosome biogenesis.	PIP4K2A PIP4K2B PIP4K2C	2.41e-06	10	96	3	25578879
Pubmed	Tankyrase is necessary for canonical Wnt signaling during kidney development.	TNKS TNKS2	7.54e-06	2	96	2	20549720
Pubmed	Severe sensory deficits but normal CNS development in newborn mice lacking TrkB and TrkC tyrosine protein kinase receptors.	NTRK2 NTRK3	7.54e-06	2	96	2	9421165
Pubmed	Tankyrase 1 and tankyrase 2 are essential but redundant for mouse embryonic development.	TNKS TNKS2	7.54e-06	2	96	2	18612384
Pubmed	Abnormal development of pacinian corpuscles in double trkB;trkC knockout mice.	NTRK2 NTRK3	7.54e-06	2	96	2	17101216
Pubmed	Proteomic Analysis of the Human Tankyrase Protein Interaction Network Reveals Its Role in Pexophagy.	TNKS TNKS2	7.54e-06	2	96	2	28723574
Pubmed	The combined effects of trkB and trkC mutations on the innervation of the inner ear.	NTRK2 NTRK3	7.54e-06	2	96	2	9881298
Pubmed	Tankyrase Requires SAM Domain-Dependent Polymerization to Support Wnt-β-Catenin Signaling.	TNKS TNKS2	7.54e-06	2	96	2	27494558
Pubmed	Discovery and characterization of targetable NTRK point mutations in hematologic neoplasms.	NTRK2 NTRK3	7.54e-06	2	96	2	32315394
Pubmed	Mapping of the tyrosine kinase receptors trkA (NTRK1), trkB (NTRK2) and trkC(NTRK3) to human chromosomes 1q22, 9q22 and 15q25 by fluorescence in situ hybridization.	NTRK2 NTRK3	7.54e-06	2	96	2	9195161
Pubmed	Lack of TrkB and TrkC signaling alters the synaptogenesis and maturation of mossy fiber terminals in the hippocampus.	NTRK2 NTRK3	7.54e-06	2	96	2	15726425
Pubmed	Human tankyrases are aberrantly expressed in colon tumors and contain multiple epitopes that induce humoral and cellular immune responses in cancer patients.	TNKS TNKS2	7.54e-06	2	96	2	18026951
Pubmed	The TrkB-positive dopaminergic neurons are less sensitive to MPTP insult in the substantia nigra of adult C57/BL mice.	NTRK2 NTRK3	7.54e-06	2	96	2	21562748
Pubmed	Structural insights into SAM domain-mediated tankyrase oligomerization.	TNKS TNKS2	7.54e-06	2	96	2	27328430
Pubmed	Discovery of tankyrase inhibiting flavones with increased potency and isoenzyme selectivity.	TNKS TNKS2	7.54e-06	2	96	2	24116873
Pubmed	PIP4K2A and PIP4K2C transcript levels are associated with cytogenetic risk and survival outcomes in acute myeloid leukemia.	PIP4K2A PIP4K2C	7.54e-06	2	96	2	31109595
Pubmed	Tropomyosin receptor kinases B and C are tumor progressive and metastatic marker in colorectal carcinoma.	NTRK2 NTRK3	7.54e-06	2	96	2	23332094
Pubmed	Inhibition of Epstein-Barr virus OriP function by tankyrase, a telomere-associated poly-ADP ribose polymerase that binds and modifies EBNA1.	TNKS TNKS2	7.54e-06	2	96	2	15795250
Pubmed	Pannexin 3 regulates skin development via Epiprofin.	SP6 PANX3	7.54e-06	2	96	2	33469169
Pubmed	Regulation of tankyrase activity by a catalytic domain dimer interface.	TNKS TNKS2	7.54e-06	2	96	2	30055800
Pubmed	Conditional deletion of TrkC does not modify limbic epileptogenesis.	NTRK2 NTRK3	7.54e-06	2	96	2	22980123
Pubmed	TrkB but not trkC receptors are necessary for postnatal maintenance of hippocampal spines.	NTRK2 NTRK3	7.54e-06	2	96	2	17442456
Pubmed	Distinct requirements for TrkB and TrkC signaling in target innervation by sensory neurons.	NTRK2 NTRK3	7.54e-06	2	96	2	11877382
Pubmed	Frequent mutations in the neurotrophic tyrosine receptor kinase gene family in large cell neuroendocrine carcinoma of the lung.	NTRK2 NTRK3	7.54e-06	2	96	2	18293376
Pubmed	Selective activation and down-regulation of Trk receptors by neurotrophins in human neurons co-expressing TrkB and TrkC.	NTRK2 NTRK3	7.54e-06	2	96	2	35536742
Pubmed	Developing inner ear sensory neurons require TrkB and TrkC receptors for innervation of their peripheral targets.	NTRK2 NTRK3	7.54e-06	2	96	2	7588071
Pubmed	Profile-based data base scanning for animal L-type lectins and characterization of VIPL, a novel VIP36-like endoplasmic reticulum protein.	LMAN2L LMAN2	7.54e-06	2	96	2	12609988
Pubmed	Haploinsufficiency in trkB and/or trkC neurotrophin receptors causes structural alterations in the aged hippocampus and amygdala.	NTRK2 NTRK3	7.54e-06	2	96	2	14622193
Pubmed	Whole proteome analysis of human tankyrase knockout cells reveals targets of tankyrase-mediated degradation.	TNKS TNKS2	7.54e-06	2	96	2	29263426
Pubmed	Phosphatidylinositol-5-Phosphate 4-Kinases Regulate Cellular Lipid Metabolism By Facilitating Autophagy.	PIP4K2A PIP4K2B	7.54e-06	2	96	2	29727621
Pubmed	Molecular insights on TNKS1/TNKS2 and inhibitor-IWR1 interactions.	TNKS TNKS2	7.54e-06	2	96	2	24291818
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	CACNA1E PDIA6 ANK2 MB PIP4K2A EML6 PGAM4 C4orf51 MAP7D2 DLG1 PIP4K2B SSRP1 NEB STK31 KRT73	9.53e-06	1442	96	15	35575683
Pubmed	PIKES Analysis Reveals Response to Degraders and Key Regulatory Mechanisms of the CRL4 Network.	TOR1AIP2 PIP4K2A PIP4K2B PIP4K2C	1.05e-05	49	96	4	31973889
Pubmed	Proximity biotinylation and affinity purification are complementary approaches for the interactome mapping of chromatin-associated protein complexes.	PDIA6 METTL3 MAP7D3 PIP4K2A ZNF516 BCORL1 PIP4K2B PIP4K2C PRDM15 VDAC1	1.21e-05	645	96	10	25281560
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	TOR1AIP2 EML5 LBX1 PIP4K2A HTATIP2 DHPS FMN2 PIP4K2B SMARCAD1 BCL11A PIP4K2C SSRP1 MAST2	1.22e-05	1116	96	13	31753913
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	CACNA1E MIA3 ANK2 NTRK2 ZNF516 DDN DLG1 TLN2 TNKS BCL11A PIP4K2C CDH11	1.40e-05	963	96	12	28671696
Pubmed	C-LTMRs mediate wet dog shakes via the spinoparabrachial pathway.	LBX1 NTRK2 NTRK3	1.91e-05	19	96	3	38915692
Pubmed	Ontogeny of excitatory spinal neurons processing distinct somatic sensory modalities.	LBX1 NTRK2 NTRK3	1.91e-05	19	96	3	24027274
Pubmed	Molecular patterning of the embryonic cranial mesenchyme revealed by genome-wide transcriptional profiling.	VWF NTRK2 LAMA1 EPHA3	2.21e-05	59	96	4	31351040
Pubmed	A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome.	PTPDC1 ZNF516 EML6 SLITRK3 SSRP1 MAST2 PPM1B EPHA3	2.22e-05	420	96	8	28065597
Pubmed	Mechanoreceptor signal convergence and transformation in the dorsal horn flexibly shape a diversity of outputs to the brain.	LBX1 NTRK2 NTRK3	2.25e-05	20	96	3	36334588
Pubmed	Survival of inner ear sensory neurons in trk mutant mice.	NTRK2 NTRK3	2.26e-05	3	96	2	9232598
Pubmed	Developmentally Programmed Tankyrase Activity Upregulates β-Catenin and Licenses Progression of Embryonic Genome Activation.	TNKS TNKS2	2.26e-05	3	96	2	32442396
Pubmed	Gangliosides activate Trk receptors by inducing the release of neurotrophins.	NTRK2 NTRK3	2.26e-05	3	96	2	12388556
Pubmed	Tankyrase inhibitors attenuate WNT/β-catenin signaling and inhibit growth of hepatocellular carcinoma cells.	TNKS TNKS2	2.26e-05	3	96	2	26246473
Pubmed	Dimerization of the Trk receptors in the plasma membrane: effects of their cognate ligands.	NTRK2 NTRK3	2.26e-05	3	96	2	30366959
Pubmed	Threonine phosphorylation of the MMAC1/PTEN PDZ binding domain both inhibits and stimulates PDZ binding.	DLG1 MAST2	2.26e-05	3	96	2	10646847
Pubmed	Multiple tumor-suppressor genes on chromosome 3p contribute to head and neck squamous cell carcinoma tumorigenesis.	ALS2CL EPHA3	2.26e-05	3	96	2	20657180
Pubmed	Human X chromosome exome sequencing identifies BCORL1 as contributor to spermatogenesis.	MAP7D3 BCORL1	2.26e-05	3	96	2	32376790
Pubmed	TRK Fusions Are Enriched in Cancers with Uncommon Histologies and the Absence of Canonical Driver Mutations.	NTRK2 NTRK3	2.26e-05	3	96	2	31871300
Pubmed	The Effects of IGF-1 on Trk Expressing DRG Neurons with HIV-gp120- Induced Neurotoxicity.	NTRK2 NTRK3	2.26e-05	3	96	2	26652865
Pubmed	Developmental dependency of Meissner corpuscles on trkB but not trkA or trkC.	NTRK2 NTRK3	2.26e-05	3	96	2	10674466
Pubmed	Expression of mRNAs for neurotrophic factors (NGF, BDNF, NT-3, and GDNF) and their receptors (p75NGFR, trkA, trkB, and trkC) in the adult human peripheral nervous system and nonneural tissues.	NTRK2 NTRK3	2.26e-05	3	96	2	8895847
Pubmed	The development of myelinated nociceptors is dependent upon trks in the trigeminal ganglion.	NTRK2 NTRK3	2.26e-05	3	96	2	15530548
Pubmed	Dok5 is substrate of TrkB and TrkC receptors and involved in neurotrophin induced MAPK activation.	NTRK2 NTRK3	2.26e-05	3	96	2	16647839
Pubmed	Gene expression of TRK neurotrophin receptors in advanced neuroblastomas in Singapore--a pilot study.	NTRK2 NTRK3	2.26e-05	3	96	2	21728718
Pubmed	Neurotrophin actions during the development of the peripheral nervous system.	NTRK2 NTRK3	2.26e-05	3	96	2	10383116
Pubmed	Dissecting the molecular determinants of clinical PARP1 inhibitor selectivity for tankyrase1.	TNKS TNKS2	2.26e-05	3	96	2	33361107
Pubmed	Pan-Trk Immunohistochemistry Is an Efficient and Reliable Screen for the Detection of NTRK Fusions.	NTRK2 NTRK3	2.26e-05	3	96	2	28719467
Pubmed	TrkB and TrkC agonist antibodies improve function, electrophysiologic and pathologic features in Trembler J mice.	NTRK2 NTRK3	2.26e-05	3	96	2	20553714
Pubmed	Developmental dependency of Merkel endings on trks in the palate.	NTRK2 NTRK3	2.26e-05	3	96	2	11295244
Pubmed	DNA methylation-dependent regulation of TrkA, TrkB, and TrkC genes in human hepatocellular carcinoma.	NTRK2 NTRK3	2.26e-05	3	96	2	21295543
Pubmed	Dysregulated TRK signalling is a therapeutic target in CYLD defective tumours.	NTRK2 NTRK3	2.26e-05	3	96	2	21552290
Pubmed	TrkB and TrkC neurotrophin receptors cooperate in promoting survival of hippocampal and cerebellar granule neurons.	NTRK2 NTRK3	2.26e-05	3	96	2	8918886
Pubmed	Somatic mutations of GUCY2F, EPHA3, and NTRK3 in human cancers.	NTRK3 EPHA3	2.26e-05	3	96	2	16941478
Pubmed	Trk receptor expression and inhibition in neuroblastomas.	NTRK2 NTRK3	2.26e-05	3	96	2	19417027
Pubmed	Role for the related poly(ADP-Ribose) polymerases tankyrase 1 and 2 at human telomeres.	TNKS TNKS2	2.26e-05	3	96	2	11739745
Pubmed	Prognostic value of tropomyosin-related kinases A, B, and C in gastric cancer.	NTRK2 NTRK3	2.26e-05	3	96	2	26459250
Pubmed	A chemical-genetic approach to studying neurotrophin signaling.	NTRK2 NTRK3	2.26e-05	3	96	2	15820690
Pubmed	Disruption of Wnt/β-Catenin Signaling and Telomeric Shortening Are Inextricable Consequences of Tankyrase Inhibition in Human Cells.	TNKS TNKS2	2.26e-05	3	96	2	25939383
Pubmed	Depletion of a putatively druggable class of phosphatidylinositol kinases inhibits growth of p53-null tumors.	PIP4K2A PIP4K2B	2.26e-05	3	96	2	24209622
Pubmed	The Trk tyrosine kinase inhibitor K252a regulates growth of lung adenocarcinomas.	NTRK2 NTRK3	2.26e-05	3	96	2	16862449
Pubmed	Tankyrase inhibition aggravates kidney injury in the absence of CD2AP.	TNKS TNKS2	2.26e-05	3	96	2	27441654
Pubmed	NeuroD regulates neuronal migration.	NTRK2 NTRK3	2.26e-05	3	96	2	23652629
Pubmed	Human trks: molecular cloning, tissue distribution, and expression of extracellular domain immunoadhesins.	NTRK2 NTRK3	2.26e-05	3	96	2	7823156
Pubmed	Molecular basis of sugar recognition by the human L-type lectins ERGIC-53, VIPL, and VIP36.	LMAN2L LMAN2	2.26e-05	3	96	2	18025080
Pubmed	Pharmacological inhibition of PI5P4Kα/β disrupts cell energy metabolism and selectively kills p53-null tumor cells.	PIP4K2A PIP4K2B	2.26e-05	3	96	2	34001596
Pubmed	Crystal Structures of Neurotrophin Receptors Kinase Domain.	NTRK2 NTRK3	2.26e-05	3	96	2	28215291
Pubmed	Arpin Regulates Migration Persistence by Interacting with Both Tankyrases and the Arp2/3 Complex.	TNKS TNKS2	2.26e-05	3	96	2	33923443
Pubmed	Differential effects of combined trk receptor mutations on dorsal root ganglion and inner ear sensory neurons.	NTRK2 NTRK3	2.26e-05	3	96	2	8575307
Pubmed	VIPL, a VIP36-like membrane protein with a putative function in the export of glycoproteins from the endoplasmic reticulum.	LMAN2L LMAN2	2.26e-05	3	96	2	12878160
Pubmed	TANK2, a new TRF1-associated poly(ADP-ribose) polymerase, causes rapid induction of cell death upon overexpression.	TNKS TNKS2	2.26e-05	3	96	2	11454873
Pubmed	ESMO recommendations on the standard methods to detect NTRK fusions in daily practice and clinical research.	NTRK2 NTRK3	2.26e-05	3	96	2	31268127
Pubmed	NTRK fusion analysis reveals enrichment in Middle Eastern BRAF wild-type PTC.	NTRK2 NTRK3	2.26e-05	3	96	2	33524004
Pubmed	Factor-inhibiting hypoxia-inducible factor (FIH) catalyses the post-translational hydroxylation of histidinyl residues within ankyrin repeat domains.	TNKS TNKS2	2.26e-05	3	96	2	21251231
Pubmed	The trk family of tyrosine protein kinase receptors.	NTRK2 NTRK3	2.26e-05	3	96	2	1751544
Pubmed	The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2.	ANK2 PTPRF KIF16B FMN2 DLG1 SLITRK3 SLC1A4 ATP10D EPHA3	2.89e-05	569	96	9	30639242
Pubmed	The RNF146 and tankyrase pathway maintains the junctional Crumbs complex through regulation of angiomotin.	AMOTL1 TNKS TNKS2	3.02e-05	22	96	3	27521426
Pubmed	Brn3a/Pou4f1 regulates dorsal root ganglion sensory neuron specification and axonal projection into the spinal cord.	LBX1 NTRK2 NTRK3	3.02e-05	22	96	3	22326227
Pubmed	Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors.	TOR1AIP2 PDIA6 ABCB7 LMAN2L GUSB PIP4K2A KIF16B PIP4K2B LMAN2 MCCC2 GMPR2 PIP4K2C DNASE2 SBSN	4.43e-05	1451	96	14	30550785
Pubmed	An autocrine function of nerve growth factor for cell cycle regulation of vascular endothelial cells.	NTRK2 NTRK3	4.51e-05	4	96	2	14706643
Pubmed	Chromosomal localization of a gene, GF1, encoding a novel zinc finger protein reveals a new syntenic region between man and rodents.	GUSB GFI1	4.51e-05	4	96	2	7789186
Interaction	CCDC85A interactions	MAP7D3 PIP4K2A PIP4K2B TNKS PIP4K2C TNKS2	5.80e-07	65	94	6	int:CCDC85A
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	ZNF708 ZNF613 ZNF516 SP6 BCL11A ZNF519 PRDM15 ZNF614 GFI1	6.37e-04	718	61	9	28
GeneFamily	Ankyrin repeat domain containing	ANK2 BCORL1 ANKDD1B TNKS TNKS2	1.33e-03	242	61	5	403
GeneFamily	Zinc fingers\|Zinc fingers PARP-type\|Poly(ADP-ribose) polymerases	TNKS TNKS2	1.47e-03	17	61	2	684
GeneFamily	Sterile alpha motif domain containing	TNKS TNKS2 EPHA3	3.27e-03	88	61	3	760
ToppCell	Severe-B_intermediate-14\|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)	ATP13A4 ZNF613 EML5 ANK2 FAM13A NEXMIF ANKDD1B	2.53e-08	142	96	7	9c7d5783302974b883bd887f997d094eb5925ec2
ToppCell	droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EML5 ANK2 PTPRF NTRK2 ZNF516 DPP3 NEB	2.07e-07	193	96	7	471e65f02937bc18d7c5facdacdf1df58cf0f839
ToppCell	droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EML5 ANK2 PTPRF NTRK2 ZNF516 DPP3 NEB	2.07e-07	193	96	7	fe451b3295d77b2bd1ac25cf29310c85835a45fe
ToppCell	Severe-B_intermediate-14\|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5)	ATP13A4 ZNF613 EML5 ANK2 NEXMIF ANKDD1B	6.52e-07	142	96	6	f9cbc266fcea19bec504be4f3a28d1173c6b2e3c
ToppCell	cellseq-Epithelial-Epithelial_Neuro-Secretory\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ANK2 TMEM176B MB MAP7D2 RTBDN NEB	3.88e-06	193	96	6	25b1e5a04724023918c8939109a92b35582d5e5c
ToppCell	droplet-Pancreas-Endocrine-21m-Epithelial\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EML5 ANK2 PTPRF ZNF516 DPP3 NEB	3.99e-06	194	96	6	0b023de48ed8a550d169bbe954881eb04bf4f981
ToppCell	Control-Epithelial_alveolar-AT_1-Differentiating_AT2\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ATP13A4 EML5 DENND1C STK31 AHNAK2	1.23e-05	138	96	5	611fe0fb284e12678f9c47a0bdbfc367a93c52b3
ToppCell	droplet-Liver-HEPATOCYTES-1m-Lymphocytic\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PTPDC1 CEP250 POP1 ARMC2 GFI1	3.27e-05	169	96	5	d721dbb317a88113b4f76688111908d00f23e899
ToppCell	3'-Child09-12-SmallIntestine-Hematopoietic-Plasma_cells-IgM_plasma_cell\|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PDIA6 EML6 LMAN2 PRDM15 SLC1A4	3.65e-05	173	96	5	77e2b2e66c89984769f2800bdeeab42f9cf9fc46
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ATP13A4 PAG1 EML5 PTPRF FAM13A	5.16e-05	186	96	5	4e94158db52df41d71e67b02b9895a358eebee0f
ToppCell	3'-Child04-06-SmallIntestine-Hematopoietic-Plasma_cells\|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PDIA6 EML6 LMAN2 PRDM15 SLC1A4	5.16e-05	186	96	5	b9fb7210f615faff0633a1c82dd3be38cb72a00b
ToppCell	TCGA-Uvea-Primary_Tumor-Uveal_Melanoma-Epithelioid_Cell\|TCGA-Uvea / Sample_Type by Project: Shred V9	HTATIP2 PGAM4 MCCC2 NSMAF VDAC1	5.16e-05	186	96	5	e8580a2093eb7e50aad55ec7fada850d2fed8ae1
ToppCell	facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MIA3 EML5 ANK2 PTPRF ZNF516	5.43e-05	188	96	5	a91443aa8fa8fa87f7501c59219daa0305bd0bbf
ToppCell	cellseq-Epithelial-Epithelial_Neuro-Secretory-PNEC-PNEC\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	TMEM176B MB MAP7D2 RTBDN NEB	5.85e-05	191	96	5	146cfd4daa2878536b4f381564c787919ad855a8
ToppCell	cellseq-Epithelial-Epithelial_Neuro-Secretory-PNEC\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	TMEM176B MB MAP7D2 RTBDN NEB	5.85e-05	191	96	5	12ea07565dc0e62cade9fbab4a2d763e47a341e3
ToppCell	proximal-Hematologic-Platelet/Megakaryocyte\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	MB ANKDD1B FMN2 MAP7D2 PIP4K2C	5.99e-05	192	96	5	522d1bb15edf1d6006b80289bd3baadb99584ae8
ToppCell	11.5-Airway-Epithelial-Epithelial\|Airway / Age, Tissue, Lineage and Cell class	CACNA1E EML5 TMEM176B MAP7D2 RTBDN	5.99e-05	192	96	5	a77d3692ff02ef7e066a9bd9e22725055a25c4d4
ToppCell	proximal-3-Hematologic-Platelet/Megakaryocyte\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	MB ANKDD1B FMN2 MAP7D2 PIP4K2C	5.99e-05	192	96	5	f5f83dec37dff32a0c471cb05d23d13b0b0ad0c9
ToppCell	proximal-Hematologic-Platelet/Megakaryocyte-3\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	MB ANKDD1B FMN2 MAP7D2 PIP4K2C	5.99e-05	192	96	5	57899a905ca3e336bb7f31edc6418a2546b9891a
ToppCell	Mesenchymal-matrix_fibroblast_2_cell\|World / Lineage, Cell type, age group and donor	ANK2 NTRK2 NTRK3 TLN2 EPHA3	5.99e-05	192	96	5	a769158c49d2b208c4224d85e7ae68c85cc372ed
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ANK2 NTRK2 LAMA1 NEB KNG1	5.99e-05	192	96	5	ee27d27e3d269764dbe8711d0b37ff9331a298a9
ToppCell	droplet-Pancreas-Endocrine-21m\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EML5 PTPRF ZNF516 DPP3 NEB	6.30e-05	194	96	5	3a3ecedcdc7691cf21775818b598208fcb980c29
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MIA3 PTPRF ZNF516 FMN2 TNKS2	6.45e-05	195	96	5	3e519cffa6144a62b06124642a14c9ff39b76554
ToppCell	LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	SLC37A1 ATP13A4 EML5 PTPRF MAP7D2	6.77e-05	197	96	5	b94645d57efe8d9e032bffb8c89af1f425c6421e
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Astrocyte\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ATP13A4 ANK2 NTRK2 FMN2 SLC1A4	6.77e-05	197	96	5	5bcf963f21d23edafef1e90dc1de24cd3b0fccce
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ATP13A4 ANK2 NTRK2 FMN2 SLC1A4	6.77e-05	197	96	5	bd7e18a0fed085cfb8ed0e478d1f172a173febbe
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte-F\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ATP13A4 ANK2 NTRK2 FMN2 SLC1A4	6.77e-05	197	96	5	7e06aee2add54eeff4a9927d9b04b5797160113b
ToppCell	3'-Child04-06-SmallIntestine-Mesenchymal-stromal_related-T_reticular\|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CACNA1E ANK2 TMEM176B CDH11 EPHA3	6.93e-05	198	96	5	5c96778cf5623c662c2259fe70f8665c14a161dd
ToppCell	Tracheal-10x3prime_v2-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	NTRK2 NTRK3 AMOTL1 NSMAF EPHA3	7.27e-05	200	96	5	410b1a31de21c57d87ca2104f61cf4a7d4dd2f30
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Krt73\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	TMEM176B LAMA1 KRT73 EPHA3	7.32e-05	103	96	4	780a94c27ac3eb138a9f284251ae094d3e97ce71
Disease	triglyceride measurement, body fat percentage	C5orf67 FAM13A SP6	3.99e-05	21	94	3	EFO_0004530, EFO_0007800
Disease	Carcinoma of lung	NTRK2 NTRK3 EPHA3	5.29e-05	23	94	3	C0684249
Disease	body fat percentage, high density lipoprotein cholesterol measurement	C5orf67 FAM13A SP6	6.84e-05	25	94	3	EFO_0004612, EFO_0007800
Disease	triglyceride measurement, very low density lipoprotein cholesterol measurement	C5orf67 SP6 PCSK7 TNKS TNKS2 ARMC2	8.35e-05	224	94	6	EFO_0004530, EFO_0008317
Disease	Schizophrenia	PAG1 LMAN2L EML5 NTRK2 NTRK3 PIP4K2A LAMA1 DLG1 BCL11A PIP4K2C ALS2CL	1.17e-04	883	94	11	C0036341
Disease	fractional shortening	HTATIP2 SLC1A4	1.49e-04	6	94	2	EFO_0009285
Disease	triglyceride measurement, low density lipoprotein cholesterol measurement	C5orf67 SP6 PCSK7 TNKS TNKS2	1.94e-04	166	94	5	EFO_0004530, EFO_0004611
Disease	chylomicron measurement, very low density lipoprotein cholesterol measurement, lipid measurement	C5orf67 SP6 PCSK7 TNKS	2.46e-04	95	94	4	EFO_0004529, EFO_0008317, EFO_0008596
Disease	chylomicron measurement, triglyceride measurement, very low density lipoprotein cholesterol measurement	C5orf67 SP6 PCSK7 TNKS	2.56e-04	96	94	4	EFO_0004530, EFO_0008317, EFO_0008596
Disease	chylomicron measurement, very low density lipoprotein cholesterol measurement	C5orf67 SP6 PCSK7 TNKS	3.74e-04	106	94	4	EFO_0008317, EFO_0008596
Disease	chylomicron measurement, very low density lipoprotein cholesterol measurement, phospholipid measurement	C5orf67 SP6 PCSK7 TNKS	4.16e-04	109	94	4	EFO_0004639, EFO_0008317, EFO_0008596
Disease	white matter hyperintensity measurement	C5orf67 ANK2 TLN2 TNKS PRDM15 CDH11	4.19e-04	302	94	6	EFO_0005665
Disease	cholesteryl ester measurement, chylomicron measurement, very low density lipoprotein cholesterol measurement	C5orf67 SP6 PCSK7 TNKS	4.31e-04	110	94	4	EFO_0008317, EFO_0008596, EFO_0010351
Disease	free cholesterol measurement, chylomicron measurement, very low density lipoprotein cholesterol measurement	C5orf67 SP6 PCSK7 TNKS	4.31e-04	110	94	4	EFO_0008317, EFO_0008591, EFO_0008596
Disease	chylomicron measurement, total cholesterol measurement, very low density lipoprotein cholesterol measurement	C5orf67 SP6 PCSK7 TNKS	4.31e-04	110	94	4	EFO_0004574, EFO_0008317, EFO_0008596
Disease	triglycerides:total lipids ratio, high density lipoprotein cholesterol measurement	C5orf67 FAM13A SP6 PCSK7 TNKS	5.24e-04	206	94	5	EFO_0004612, EFO_0020947
Disease	Intellectual Disability	CACNA1E LMAN2L MAP7D3 LAMA1 DHPS BCL11A SLC1A4	5.76e-04	447	94	7	C3714756
Disease	Malignant neoplasm of breast	NLRP14 VWF ANK2 LBX1 BCORL1 POP1 KIF16B MAP7D2 BCL11A ALS2CL PURG	6.18e-04	1074	94	11	C0006142
Disease	abdominal adipose tissue measurement	C5orf67 SP6 TLN2	6.53e-04	53	94	3	EFO_0803316
Disease	very low density lipoprotein cholesterol measurement, lipid measurement	C5orf67 SP6 PCSK7 TNKS TNKS2	7.05e-04	220	94	5	EFO_0004529, EFO_0008317
Disease	testosterone measurement	C5orf67 MIA3 ANK2 TMEM176B PTPRF BCORL1 ANKDD1B LMAN2 ZNF519 TNKS2 GFI1 GSS	7.30e-04	1275	94	12	EFO_0004908
Disease	triglycerides:total lipids ratio, intermediate density lipoprotein measurement	C5orf67 SP6 PCSK7 ANKDD1B	7.40e-04	127	94	4	EFO_0008595, EFO_0020947
Disease	very low density lipoprotein cholesterol measurement, phospholipid measurement	C5orf67 SP6 PCSK7 TNKS TNKS2	8.44e-04	229	94	5	EFO_0004639, EFO_0008317
Disease	very low density lipoprotein particle size measurement	C5orf67 SP6 PCSK7 TNKS	8.79e-04	133	94	4	EFO_0008594
Disease	atrial fibrillation (is_implicated_in)	VWF ANK2	8.91e-04	14	94	2	DOID:0060224 (is_implicated_in)
Disease	cholesterol to total lipids in IDL percentage	C5orf67 PCSK7 ANKDD1B	9.39e-04	60	94	3	EFO_0022233
Disease	cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement	C5orf67 FAM13A SP6 PCSK7 LMAN2	1.10e-03	243	94	5	EFO_0004612, EFO_0020944
Disease	teratocarcinoma-derived growth factor 1 measurement	NTRK2 ALS2CL	1.17e-03	16	94	2	EFO_0008297
Disease	Abnormal behavior	BCORL1 DHPS	1.17e-03	16	94	2	C0233514
Disease	body fat percentage, type 2 diabetes mellitus	C5orf67 SP6	1.32e-03	17	94	2	EFO_0007800, MONDO_0005148
Disease	triglycerides to phosphoglycerides ratio	C5orf67 SP6 PCSK7	1.35e-03	68	94	3	EFO_0022327
Disease	triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement	C5orf67 PCSK7 ANKDD1B TNKS	1.37e-03	150	94	4	EFO_0004611, EFO_0020947
Disease	very low density lipoprotein cholesterol measurement	C5orf67 SP6 PCSK7 TNKS TNKS2	1.48e-03	260	94	5	EFO_0008317
Disease	unipolar depression, bipolar disorder	CACNA1E ATP13A4 LMAN2L NTRK2	1.58e-03	156	94	4	EFO_0003761, MONDO_0004985
Disease	bipolar disorder (is_marker_for)	VWF NTRK2	1.66e-03	19	94	2	DOID:3312 (is_marker_for)
Disease	insulin measurement	CACNA1E PAG1 C5orf67 FAM13A SP6	1.67e-03	267	94	5	EFO_0004467
Disease	cancer (implicated_via_orthology)	PIP4K2A DLG1 PIP4K2B PIP4K2C SSRP1	1.69e-03	268	94	5	DOID:162 (implicated_via_orthology)
Disease	reticulocyte count	C5orf67 VWF EML6 SP6 C4orf51 TLN2 LMAN2 BCL11A MAST2 DNASE2	1.83e-03	1045	94	10	EFO_0007986
Disease	cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement	C5orf67 FAM13A SP6 PCSK7 LMAN2	1.92e-03	276	94	5	EFO_0004612, EFO_0020943
Disease	free cholesterol in large HDL measurement	C5orf67 SP6 ANKDD1B	2.08e-03	79	94	3	EFO_0022157
Disease	high density lipoprotein particle size measurement	C5orf67 FAM13A SP6 PCSK7	2.17e-03	170	94	4	EFO_0008592
Disease	HMG CoA reductase inhibitor use measurement	C5orf67 MIA3 MORN1 SP6	3.17e-03	189	94	4	EFO_0009932

Protein segments in the cluster

Peptide	Gene	Start	Entry
ALLDGKNVNAGGHKL	VDAC1	261	P21796
HQALHGKKDFPVLGA	ALS2CL	316	Q60I27
GLAVIGVFLKLGKHH	CA5B	176	Q9Y2D0
GEGAHGIVFKAKHVE	CDK20	11	Q8IZL9
GEKDHELRGNHGAKE	CACNA1E	956	Q15878
MGHFEKGQHALLNEG	ATP13A4	1	Q4VNC1
LPSHLKNGGDQGKRH	ARMC2	216	Q8NEN0
GGAAHKDGKLQIGDK	DLG1	356	Q12959
ASDSGKEHNGVRGKH	BCORL1	1166	Q5H9F3
KGSIGLLLGKEHHEH	AMOTL1	826	Q8IY63
ADNLKKGGGALLHSV	DENND1C	426	Q8IV53
HHLKGSREGKEGEQI	DDN	366	O94850
HAVGGKLTDIHGNVL	BPNT1	256	O95861
EKQHGDAGLLNGKAE	ATP10D	696	Q9P241
VDGVQKDHHGTLEGK	KIF16B	1081	Q96L93
NALHLAAKEGHVGLV	ANK2	66	Q01484
GRKHGHGKLLFKDGS	MORN1	46	Q5T089
ENKAIHDLGKAHGSL	HTATIP2	226	Q9BUP3
AGRHGDDLKHTKNEI	KRT73	336	Q86Y46
HGTGKKNLHGDGIAL	LMAN2	121	Q12907
EHIKLGGGEKARALH	MCCC2	61	Q9HCC0
DKHASEKHAAAAGGK	MAP7D2	366	Q96T17
GHGLHADKGAGVKVE	GFI1	226	Q99684
KHGDLNKFLRAHGPD	NTRK3	621	Q16288
QKHLGKKRQHGGDEG	LENG1	161	Q96BZ8
LGEKHKRGHLAEAEG	BCL11A	566	Q9H165
HQLGKAALQHGVIAG	PCSK7	301	Q16549
QVGLHELLGHGSGKL	DPP3	446	Q9NY33
KIHGQGKKNLHGDGL	LMAN2L	116	Q9H0V9
LEVLGGSHKHAVDGA	GCN1	151	Q92616
ADAAHGLKGHIISDG	GMPR2	206	Q9P2T1
HGNSLQGIAKHVEGL	PGAM4	186	Q8N0Y7
LQEGKVAIHCHAGLG	PTPDC1	181	A2A3K4
ERKGNEKDGGHTQHF	FAM13A	511	O94988
LNHGKEHCLVGVKGN	METTL3	476	Q86U44
LDASLAHHLIGGAGK	PAX4	326	O43316
DSLLHHKQDGPGQDK	PANX3	86	Q96QZ0
FVADRGVKHHSGGEK	POP1	26	Q99575
ADLGTHKSLKGNAHA	SLC37A1	446	P57057
EKGKHGILGAQGQEH	C5orf67	76	F2Z3F1
RGHTKGVLLLDHDGG	DNASE2	111	O00115
LGGGVVKHHIANANL	DHPS	281	P49366
HGVNKHEDADIRGKG	GUSB	346	P08236
HGSAQVKGHGKKVAD	HBA1;	51	P69905
GKAHAALQGKEQHLL	CEP250	1971	Q9BV73
EVKEALAHHFGQGGL	GIMD1	91	P0DJR0
HGHHEKGKEGQVLQR	CDH11	36	P55287
ADEKRLHFGNGHLKL	EPHA3	576	P29320
AVGGQAEDHLKLKDG	MAP7D3	641	Q8IWC1
LEAAEGHAKEGQGIK	MAST2	441	Q6P0Q8
GKHGENGANRHFTKA	NSMAF	86	Q92636
EQQHGLGHGHKFKLD	KNG1	466	P01042
LGHGHILVGTKNGEI	EML5	966	Q05BV3
LGHGHILVGTKNGEI	EML6	966	Q6ZMW3
AAHLLAAADKHAQGG	LBX1	56	P52954
GHLLRTKAIEHADGG	GSS	446	P48637
AKKHRADGGLAAGLS	FMN2	466	Q9NZ56
KVAHEINHGIGQAGK	SBSN	96	Q6UWP8
GKEAEKFGQGAHHAA	SBSN	236	Q6UWP8
GVHHTAGQVGKEAEK	SBSN	281	Q6UWP8
KEAEKFGQGAHHAAG	SBSN	291	Q6UWP8
FGKETEKLGHGVHHG	SBSN	361	Q6UWP8
IHHTAGQAGKEGDIA	SBSN	426	Q6UWP8
GVHHTLEQAGKEADK	SBSN	461	Q6UWP8
HTGVHQAGKEAEKLG	SBSN	481	Q6UWP8
GKEVEKLGQGAHHAA	SBSN	506	Q6UWP8
GKGVLKHLHGRCDSE	C4orf51	161	C9J302
AHAAKTVKHGAGAEI	PIP4K2A	371	P48426
VKVGAVDADKHHSLG	PDIA6	76	Q15084
GKDDQHFTVTGLHKG	PTPRF	871	P10586
AHAAKTVKHGAGAEI	PIP4K2C	386	Q8TBX8
LKGHRQEHGHSKEQG	PURG	131	Q9UJV8
HHGLAADLGKGKLHL	RTBDN	41	Q9BSG5
DGGKGHHLPSENLGK	TOR1AIP2	96	Q8NFQ8
VHKHGLNGILADEMG	SMARCAD1	511	Q9H4L7
KEVNAEHHIKGKGRG	MIA3	456	Q5JRA6
HASNHKEDGGLKGTL	NEXMIF	661	Q5QGS0
DLAEGKHGKAAKRSH	PRDM15	1286	P57071
KDDLHSDLHNGKQPG	LAMA1	411	P25391
AHAAKTVKHGAGAEI	PIP4K2B	381	P78356
HLDGKHVVFGQVIKG	PPID	141	Q08752
DLAGFRHHEKNGGVV	SLITRK3	856	O94933
DKPKTEKHNAHGAGN	PPM1B	6	O75688
DGGKKKHLHNCHIPG	SP6	246	Q3SY56
AAAAHLEKGHSGKAK	PAG1	191	Q9NWQ8
EEEKATLGTNGHHGL	PAG1	396	Q9NWQ8
AGAIVHEKHPGKLAG	TMEM176B	111	Q3YBM2
VALGHGLKLLTKNGH	SSRP1	56	Q08945
QGKVAERGTHHGLLA	ABCB7	681	O75027
KDKGGNTALHLAAKH	ANKDD1B	231	A6NHY2
VHEGAGLKGHLPKLQ	AHNAK2	4371	Q8IVF2
KHGDLNKFLRAHGPD	NTRK2	621	Q16620
KGVAQGLHTLHKADI	STK31	836	Q9BXU1
SDLHNKEHSGGGKRA	ZNF516	711	Q92618
RGLHLGHQKIHTGEK	ZNF519	276	Q8TB69
LHNSLVKLKHGAGVA	VWF	451	P04275
GDALGAGILHHLNQK	SLC1A4	466	P43007
HGADVHAKDKGGLVP	TNKS	391	O95271
HGADVHAKDKGGLVP	TNKS	706	O95271
GHEELKEIGINAYGH	TNKS	1061	O95271
LQHGADVHAKDKGDL	TNKS2	231	Q9H2K2
LQHGADVHAKDKGGL	TNKS2	546	Q9H2K2
DVHAKDKGGLVPLHN	TNKS2	551	Q9H2K2
TALGGILKKKGHHEA	MB	71	P02144
GCKSVDEHKLHKGGH	ZNF708	111	P17019
DEHKLHKGGHKGLNR	ZNF708	116	P17019
GVNGDGKSFLHAKHE	ZNF613	156	Q6PF04
AKEGGGNPKAQHTHD	TLN2	1781	Q9Y4G6
VEFIGGEKTLLHGKH	ZNF614	156	Q8N883
KSLAGKPEDFHHGIA	NLRP14	141	Q86W24
LGHHIGARNIKDDPK	NEB	3531	P20929